Neu, Maria https://orcid.org/0009-0003-0023-7577
Wöhrl, Carolin Michaela
Walter, Renate
Balagiannis, Nikolaos
Poettgen, Christoph
Käsmann, Lukas
Stuschke, Martin
Dannecker, Christian
Stüben, Georg
Kahl, Klaus-Henning
Funding for this research was provided by:
Universität Augsburg
Article History
Received: 29 January 2025
Accepted: 11 April 2025
First Online: 21 May 2025
Declarations
:
: K.H. Kahl has received speaker honoraria and travel grants from ELEKTA AB, Varian Medical Systems, Carl Zeiss Meditec AG, AstraZeneca, Bristol Myers Squibb, MSD, Merck, Sanofi-Aventis and IcoTec.; L. Käsmann receives an unrestricted institutional research grant from AstraZeneca and is supported by a Deutsche Krebshilfe grant (#70116242) unrelated to the work mentioned here. Additionally, L. Käsmann has received honoraria from AMGEN, AstraZeneca, and the German Cancer Society. M. Neu, C.M. Wöhrl, R. Walter, N. Balagiannis, C. Poettgen, M. Stuschke, C. Dannecker and G. Stüben declare that they have no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.